Complete Response in a Patient With Chemorefractory EGFR-Amplified, PD-L1-Positive Metastatic Gastric Cancer Treated By Dual Anti-EGFR and Anti-PD-1 Monoclonal Antibody Therapy

JCO Precis Oncol. 2020 Oct 2;4:PO.20.00239. doi: 10.1200/PO.20.00239. eCollection 2020.
No abstract available

Publication types

  • Case Reports